“Interest in developing and using antimicrobial nanomaterials is on the rise in advanced nations, particularly for building and construction applications,” said Hamizah Shamsudeen, Chemicals, Materials & Nutrition Research Analyst at Frost & Sullivan. “Additionally, these implementations offer a high total surface area that enables the development of highly effective antimicrobial surface technologies.”
Shamsudeen added: “With biotechnological processes producing novel molecules, metal-based antimicrobials can profile efficient solutions to infection care and health. However, they require proper handling for long-term use in human and agricultural health, with bioremediation as a recovery option.”
Market participants can reap the benefits of expanding the antimicrobial technologies market by:
Collaborating with industrial stakeholders in technology development to understand the risk of toxicity of graphene oxide (GO) composites, as this will enhance the technology’s commercialization potential.
Pivoting the adoption of nanomaterials for imparting multi-functional benefits in packaging and FMCG industries.
Focusing on the solvent-free extrusion process through industrial partnerships to drive the adoption of metal and metal-oxide ions as antimicrobial agents, providing a sustainable alternative for antimicrobial technology.
Leveraging digital technologies, such as digital twins and electronic health and medical records, to improve antimicrobial features.
For over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors. We apply actionable insights to navigate economic changes, identify disruptive technologies, and formulate new business models to create a stream of innovative growth opportunities that drive future success. Contact us: Start the discussion
Growth Opportunities for Global Antimicrobial Technologies Enabled by COVID-19